New 3D maps reveal inner workings of immune cell gene expression

The COVID-19 pandemic has highlighted how our small genetic differences can have a tremendous effect on how our bodies respond to disease. Researchers have created 3D maps of how enhancer sequences and genes interact in several types of immune cells. Their new study opens the door to understanding individual risk for diseases from asthma to cancer.

Digging Deep For Differences In Duchenne Muscular Dystrophy

DALLAS – Dec. 21, 2020 – A UT Southwestern research team has catalogued gene activity in the skeletal muscle of mice, comparing healthy animals to those carrying a genetic mutation that causes Duchene muscular dystrophy (DMD) in humans. The findings, published online recently in PNAS, could lead to new treatments for this devastating degenerative disease and insights into factors that affect muscle development.

Prostate cancer regulator plays role in COVID-19, providing a promising treatment lead

By taking a lesson from prostate cancer, researchers now have a promising lead on a treatment for COVID-19. They found that, just like in prostate cancer, TMPRSS2 is regulated by the androgen receptor in the lungs. And notably, blocking the androgen receptor led to lower expression of TMPRSS2, which led to decreased coronavirus infection in mice and cellular models.

Moffitt Researchers Discover Potential New Drug Target to Treat Cutaneous T Cell Lymphoma

In order to improve their understanding of how CTCL develops in hopes of developing new therapies, a team of Moffitt immunologists and hematologists conducted a series of studies. In an article published in The Journal of Clinical Investigation, they demonstrate that decreased expression of the protein SATB1 contributes to CTCL development and that drugs that cause SATB1 to become re-expressed may be potential treatment options for this disease.

Discovery: How Colorado Potato Beetles Beat Pesticides

New research shows that pesticide alter how Colorado potato beetles manage their DNA. These changes were passed down two generations suggesting that rapid resistance to pesticides may not require beetles to evolve their genetic code. Instead they may simply use existing genes to tolerate toxins already found in potatoes. The scientists were surprised that these epigenetic changes, triggered by a single tiny dose of pesticide, were maintained through multiple rounds of sexual reproduction.

Researchers illuminate neurotransmitter transport using X-ray crystallography and molecular simulations

Scientists from the MIPT Research Center for Molecular Mechanisms of Aging and Age-Related Diseases have joined forces with their colleagues from Jülich Research Center, Germany, and uncovered how sodium ions drive glutamate transport in the central nervous system. Glutamate is the most important excitatory neurotransmitter and is actively removed from the synaptic cleft between neurons by specialized transport proteins called excitatory amino acid transporters (EAATs)

Big step with small whirls

Skyrmions are small magnetic objects that could revolutionize the data storage industry and also enable new computer architectures. However, before they can be utilized in such applications, there are still a number of challenges that need to be overcome. A team of Empa researchers has now succeeded for the first time in producing a tunable multilayer system in which two different types of skyrmions – the future bits for “0” and “1” – can exist at room temperature, as they recently reported in the renowned journal Nature Communications.

Stroke and Altered Mental State Increase Risk of Death for COVID-19 Patients

People hospitalized with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying than other COVID-19 patients, according to a study published online today by researchers at Montefiore Health System and Albert Einstein College of Medicine in the journal Neurology®, the medical journal of the American Academy of Neurology. These findings have the potential to identify and focus treatment efforts on individuals most at risk and could decrease COVID-19 deaths.

Yale study leads to FDA approval of drug to treat non-small cell lung cancer

Based on results of a clinical trial led by Yale Cancer Center researchers, the U.S. Food and Drug Administration has approved osimertinib for the treatment of adults with early-stage, non-small cell lung cancer (NSCLC) with EGFR gene mutations, which occurs in about 10 percent of patients.

Largest Study of Its Kind Identifies Which COVID-19 Patients Face the Greatest Risk of Mortality During Hospitalization

Hospitalized COVID-19 patients have a greater risk of dying if they are men or are obese or have complications from diabetes or hypertension, according to a new study conducted by University of Maryland School of Medicine (UMSOM) researchers. In a study published in the journal Clinical Infectious Diseases, the researchers evaluated nearly 67,000 hospitalized COVID-19 patients in 613 hospitals across the country to determine link between common patient characteristics and the risk of dying from COVID-19.

Researchers discover new way to deliver DNA-based therapies for diseases

University of Minnesota Twin Cities researchers have created a new polymer to deliver DNA and RNA-based therapies for diseases. For the first time in the industry, the researchers were able to see exactly how polymers interact with human cells when delivering medicines into the body. This discovery opens the door for more widespread use of polymers in applications like gene therapy and vaccine development.

PNNL Researchers Track Radioiodine’s Chemical Evolution

PNNL researchers are examining the volatile radioisotope iodine as it evolves in the atmosphere and as it lands on a filtering surface. A more detailed understanding of the interactions and chemical evolution of radioiodine could help first responders’ decision-making after the release of volatile iodine into the environment, which happened following nuclear power plant accidents in 1986 at Chernobyl and in 2011 at Fukushima.

Statewide Retail Alcohol Compliance Checks Cut Drink-Driving Crashes Among Drivers Under-21 Years Old

Regular statewide retail checks for compliance with the legal drinking age are associated with a sustained reduction in alcohol-related crashes for drivers aged under 21, according to an analysis of 11 years’ data from South Carolina. Previous research has shown that reductions in underage drinking lead to a decrease in drink-driving and alcohol-related crashes. However, few studies have assessed the impact of purposeful alcohol compliance checks – in which authorities use an underage informant to attempt to buy alcohol – on drink-related road accidents. The new study, reported in Alcoholism: Clinical and Experimental Research, evaluated the impact of the South Carolina Alcohol Enforcement Team (AET) program for reducing retail alcohol access to underage youth on drinking and driving crashes among drivers under 21 years old.

Wildfire smoke carry microbes that can cause infectious diseases

Wildfire smoke contains microbes, infectious agents that might cause diseases. In a perspective piece published in Science, researchers at UC Davis Health and the University of Idaho proposed a multidisciplinary approach to study the health impacts of microbes carried by wildfire smokes.

Insurance status doesn’t alter trauma care outcome in Ghana

A team of Ghanaian and U.S. researchers examined whether having insurance affected trauma patients’ out-of-pocket costs and their chances to get timely surgical care after being admitted to Komfo Anokye Teaching Hospital, a large teaching hospital in Kumasi, Ghana, a city of 3.3 million. The study was published in the Bulletin of the World Health Organization. Collaborators came from Stanford University and the University of Utah.

Individuals with high ADHD-traits are more vulnerable to insomnia

Individuals with high ADHD-traits that do not meet the criteria for a diagnosis are less able to perform tasks involving attentional regulation or emotional control after a sleepless night than individuals with low ADHD-traits, a new study from Karolinska Institutet published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging reports.